Two Sigma Securities, LLC Novartis Ag Transaction History

Two Sigma Securities, LLC

$10.3 Billion
Q1 2024

A detailed history of Two Sigma Securities, LLC transactions in Novartis Ag stock. As of the latest transaction made, Two Sigma Securities, LLC holds 4,275 shares of NVS stock, worth $461,956. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,275

Previous 6,194 30.98%

Holding current value

$461,956

Previous $625,000 33.92%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $182,823 - $208,153	-1,919 Reduced 30.98%	4,275 $413,000
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $571,520 - $628,938	6,194 New	6,194 $625,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $558,314 - $683,722	7,390 Added 53.54%	21,193 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $27,083 - $31,675	363 Added 2.7%	13,803 $1.05 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $640,214 - $745,406	7,951 Added 144.85%	13,440 $1.14 Million

Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $239,976 - $265,359	-3,011 Reduced 35.42%	5,489 $480,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $99,705 - $112,235	-1,232 Reduced 12.66%	8,500 $742,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $586,718 - $646,529	-6,859 Reduced 41.34%	9,732 $846,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $16,796 - $19,211	223 Added 1.36%	16,591 $1.6 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $29,316 - $32,643	398 Added 2.49%	16,368 $1.41 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $826,106 - $955,563	-12,341 Reduced 43.59%	15,970 $1.38 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $6.73 Million - $7.61 Million	-103,693 Reduced 78.55%	28,311 $2.14 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $9.29 Million - $11.1 Million	132,004 New	132,004 $10.7 Million

Others Institutions Holding NVS

# of Institutions

1,350

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Novartis Ag Transaction History